All Sauce from Weekly Sauce:

When implanted heart devices get infected, doctors recommend surgery to remove them, but many patients ignore that advice, a new study reveals. More than eight in 10 patients with an infected implant (such as a defibrillator or pacemaker) choose antibiotic treatment instead, though it puts their life at risk. Having the devices removed carries a…  read on >  read on >

Alzheimer’s patients are often drowsy during the day, but it might not be because of poor sleep at night. Instead, a clinical trial that monitored patients’ sleep and then studied their brains after death discovered an entirely different reason for such sleepiness — they suffer a loss of neurons that help keep a person awake.…  read on >  read on >

The introduction of HAART (highly active anti-retroviral therapy) in the mid-1990s revolutionized the treatment of HIV/AIDS, halting disease progression and dramatically extending lives. Now, a small new study suggests another potential use for one of the standard HAART medications: It halted disease progression in about a quarter of patients who were battling advanced colon cancer.…  read on >  read on >

Just weeks after dropping masking rules, some overseas airlines have canceled hundreds of flights as they struggle with staffing shortages related to COVID-19. This comes as the leading U.S. airlines have urged the Biden administration to scrap a mask mandate for passengers. Swiss airline EasyJet removed its mask mandate on March 27, after the United…  read on >  read on >

(HealthDay News) – Outlining a daunting timeline for development of any updated coronavirus vaccine for next fall, federal health officials told an expert advisory panel on Wednesday that clinical trials of potential candidates would have to begin by next month, and a final formula chosen by June, to meet that tight deadline. The assessment came…  read on >  read on >

Urinary tract infections are common and usually simple to treat. But for people who become sick enough to land in the hospital with one, an experimental antibiotic may soon offer a new treatment option — taken by mouth instead of delivered by IV. In a clinical trial, researchers found that the pill, called tebipenem HBr,…  read on >  read on >